CollPlant Biotechnologies (CLGN) Non-Current Assets (2017 - 2025)

CollPlant Biotechnologies (CLGN) posted Non-Current Assets of $4.0 million for Q4 2025, down 16.1% on a QoQ basis from $4.8 million in Q2 2025, and down 99.93% year-over-year from $5.5 billion in Q4 2024.

CollPlant Biotechnologies (CLGN) Non-Current Assets (2017 - 2025) Analysis & Trends

CollPlant Biotechnologies' Non-Current Assets history runs 9 years deep, the most recent figure standing at $4.0 million for Q4 2025.

  • Quarterly Non-Current Assets fell 99.93% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (down 99.93% YoY) and the FY2025 annual result came in at $4.0 million, down 99.93% from the prior year.
  • Non-Current Assets was $4.0 million for Q4 2025 at CollPlant Biotechnologies, down from $4.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $6137.0 billion in Q4 2021 and bottomed at $4.0 million in Q4 2025.
  • A 5-year average of $342.9 billion and a median of $6.5 million in 2023 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Non-Current Assets surged 118818873.86% — and 2025, when it plunged 99.93%.
  • CollPlant Biotechnologies' Non-Current Assets stood at $6137.0 billion in 2021, then sank by 99.9% to $6.1 billion in 2022, then plunged by 99.9% to $6.1 million in 2023, then jumped by 90496.33% to $5.5 billion in 2024, then plunged by 99.93% to $4.0 million in 2025.
  • Business Quant data shows CLGN's Non-Current Assets at $4.0 million in Q4 2025, $4.8 million in Q2 2025, and $5.5 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 66,741.39 Bn 66,741.11 Bn - 21.65 Mn
2 Nanobiotix 1,913.26 Bn 1,913.20 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.02 Bn 466.23 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 122.17 Bn 114.92 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 69.85 Bn 61.10 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - 289.41 Mn
8 Argenx Se 55.60 Bn 50.42 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.39 Bn 34.38 Bn 959.66 Mn 910.24 Mn
10 CollPlant Biotechnologies 4.63 Mn 4.63 Mn -243,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.04 Mn
Jun 30, 2025 4.81 Mn
Dec 31, 2024 5.53 Bn
Sep 30, 2024 5.95 Bn
Jun 30, 2024 6.23 Mn
Mar 31, 2024 5.82 Bn
Dec 31, 2023 6.10 Mn
Sep 30, 2023 6.35 Bn
Jun 30, 2023 6.71 Mn
Mar 31, 2023 6.70 Mn
Dec 31, 2022 6.11 Bn
Sep 30, 2022 6.10 Mn
Jun 30, 2022 6.14 Mn
Mar 31, 2022 6.11 Mn
Dec 31, 2021 6,137.00 Bn
Sep 30, 2021 5.73 Mn
Jun 30, 2021 5.25 Mn
Mar 31, 2021 5.17 Bn
Dec 31, 2020 5.17 Mn
Sep 30, 2020 5.32 Mn